Form 4 Filing for Immunovant, Inc. - Officer/Director Stock Transaction

This Form 4 filing details a stock transaction by Robert Graham Susman, a director at Immunovant, Inc. On May 1, 2026, Susman disposed of 2,502 shares of Common Stock. The transaction was executed under a Rule 10b5-1 trading plan adopted on December 30, 2025. The shares were sold at a weighted average price of $27.17 per share, with individual sales ranging from $26.84 to $27.49. Following this transaction, Susman holds 36,394 shares of Immunovant, Inc. common stock. This filing is made pursuant to Section 16 of the Securities Exchange Act of 1934.